Key facts
- This page summarizes Michael O Johnson's Form 4 filing for HERBALIFE LTD. (HLF).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Feb 2025, 20:12.
Michael O Johnson - 21 Feb 2025 Form 4 Insider Report for HERBALIFE LTD. (HLF)
- Reporting relationship
- Chairman & CEO, Director
- Issuer ticker
- HLF
- Reported as of
- 21 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Feb 2025, 20:12:05 UTC
- Prior SEC filing
- 19 Feb 2025
- Next SEC filing
- 03 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- Alaaeddine Sahibi, as Attorney-In-Fact for Micahel O. Johnson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael O Johnson filed Form 4 for HERBALIFE LTD. (HLF) on 25 Feb 2025.
Change
- Previous filing in this sequence was filed on 19 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HLF
transaction
Derivative
Stock Appreciation Rights
Award
- Transaction value
- $0
- Shares
- +442,477
- Change %
- Price
- $0.000000
- Shares after
- 442,477
- Date
- 21 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 442,477
- Exercise price
- $8.31
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in two installments, 50% on February 21, 2026 and 50% on the date of the Company's Annual General Meeting of Shareholders in 2026 , subject to certain conditions of his service as CEO and/or member of the Issuer's Board of Directors.